22.00EUR+0.92%Mkt Cap: 221.50M EURP/E: 46.81Last update: 2026-06-01
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap221.50M EUR
Enterprise Value214.83M EUR
Revenue (TTM)168.60M EUR
Gross Profit76.84M EUR
Net Income (TTM)4.87M EUR
Revenue/Share16.45 EUR
Last Price22.00 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees343
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0013240934
Valuation
P/E (Trailing)46.81
P/E (Forward)19.29
PEG—
EV/EBITDA9.57
EV/Revenue1.27
P/S1.30
P/B1.19
EPS (TTM)0.47
EPS (Forward)1.13
52W Range
20.4029% of range25.95
52W High25.95 EUR
52W Low20.40 EUR
Profitability
Gross Margin45.58%
Oper. Margin5.57%
EBITDA Margin13.31%
Profit Margin2.89%
ROE2.65%
ROA1.89%
Growth
Revenue Growth8.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.85M EUR
CapEx (TTM)12.57M EUR
FCF Margin3.74%
FCF Yield2.85%
Net Debt-4.66M EUR
Net Debt/EBITDA-0.21
Balance Sheet
Debt/Equity0.09
Current Ratio2.63
Quick Ratio1.65
Book Value/Sh18.27 EUR
Cash/Share2.052 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 1, 2017
Analyst Consensus
Rating—
Target (Mean)30.00 EUR
Target Range30.00 EUR – 30.00 EUR
# Analysts1
Ownership
Shares Out.10.07M
Float252.61K
Insiders0.08%
Institutions97.56%
Technical
SMA 5022.61 (-2.7%)
SMA 20023.89 (-7.9%)
Beta0.72
S&P 52W Chg27.94%
Avg Vol (30d)2.40K
Avg Vol (10d)1.34K
Technical Indicators
RSI (14)44.9
MACD-0.2974
MACD Signal-0.2682
MACD Hist.-0.0292
BB Upper22.99 EUR
BB Middle22.18 EUR
BB Lower21.37 EUR
BB Width7.35%
ATR (14)0.9344 EUR
Vol Ratio (20d)1.13x